DAIICHI SANKYO CO LTD Share Price Today: Live Updates & Key Insights
DAIICHI SANKYO CO LTD share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.
DAIICHI SANKYO CO LTD Share Price Chart
DAIICHI SANKYO CO LTD
DAIICHI SANKYO CO LTD Share Price Performance
DAIICHI SANKYO CO LTD Institutional Holdings
DAIICHI SANKYO CO LTD Market Status
DAIICHI SANKYO CO LTD Fundamentals
Market Cap 32995.80 M
PB Ratio 3.0828
PE Ratio 19.1383
Enterprise Value 30929.33 M
Total Assets 3456119.00 M
Volume null
DAIICHI SANKYO CO LTD Company Financials
About DAIICHI SANKYO CO LTD & investment objective
Company Information Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule that targets colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3 harboring an internal tandem duplication mutation for the treatment of symptomatic TGCT; Vanflyta, a FLT3 inhibitor to treat adult patients with acute myeloid leukemia; Injectafer, a ferric carboxymaltose injection for the treatment of iron deficiency; and DATROWAY to treat adult patients with breast cancer and NSCLC. It also provides Liziana and Savaysa, which are direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT, which are antihypertensive agents; Nilemdo, an oral treatment that lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe to reduce cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia and Tenelia for the treatment of type 2 diabetes mellitus; Emgalty and Reyvow to treat migraine attacks; Pralia for the treatment of osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark to treat bone complications and GCTB; Tarlige for the treatment of neuropathic pain; Venofer to treat iron deficiency anemia; and Vimpat, an anti-seizure medication. Further, it provides vaccines for the treatment of COVID-19, influenza infections, adsorbed cell culture-derived influenza (H5N1) influenza infections, measles/rubella infections, and mumps infections. The company has a strategic collaboration with Lunit Inc. for the development of biomarker discovery and optimize translational research. Daiichi Sankyo Company, Limited was founded in 1899 and is headquartered in Chuo, Japan.
Organisation Drug Manufacturers - General
Employees 19765
Industry Drug Manufacturers - General
CEO Mr. Hiroyuki Okuzawa
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
DAIICHI SANKYO CO LTD FAQs
What is the share price of DAIICHI SANKYO CO LTD today?
The current share price of DAIICHI SANKYO CO LTD is $null.
Can I buy DAIICHI SANKYO CO LTD shares in India?
Yes, Indian investors can buy DAIICHI SANKYO CO LTD shares by opening an international trading and demat account with Motilal Oswal.
How to buy DAIICHI SANKYO CO LTD shares in India?
You can easily invest in DAIICHI SANKYO CO LTD shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy DAIICHI SANKYO CO LTD shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of DAIICHI SANKYO CO LTD.
Can I buy fractional shares of DAIICHI SANKYO CO LTD?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of DAIICHI SANKYO CO LTD?
DAIICHI SANKYO CO LTD has a market cap of $32995.80 M.
In which sector does DAIICHI SANKYO CO LTD belong?
DAIICHI SANKYO CO LTD operates in the Drug Manufacturers - General sector.
What documents are required to invest in DAIICHI SANKYO CO LTD stocks?
To invest, you typically need:
What is the PE and PB ratio of DAIICHI SANKYO CO LTD?
The PE ratio of DAIICHI SANKYO CO LTD is 19.14 and the PB ratio is 3.08.